Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

INVION LIMITED

INVESTOR PRESENTATION - INVION LIMITED

ASX:IVX

INVION LIMITED

Health Care

Invion Limited (IVX) is a clinical-stage drug development company in the biotechnology and pharmaceutical industry in Australia. IVX has three key development programs: INV102 for inflammatory respiratory disease; INV104, a leukotriene receptor antagonist; and, INV103, a modified, naturally occurring human protein. Former Names Cbio Limited (CBZ), 04/09/2012.

Read more

Market Cap

60.54m

Price at Close

$0.011

4w avg. Volume

821.26k

4w avg. Turnover

$8.57k

Announcements
announcementt+2 movementdate
  • Change of Director's Interest Notice - Thian Chew

    Shareholder Details

  • 0.00%

    28 Oct 2020

0.00%

28 Oct 2020
  • Change of Director's Interest Notice - Alan Yamashita

    Shareholder Details

  • 0.00%

    28 Oct 2020

0.00%

28 Oct 2020
  • Appendix 3G

    Issued Capital

  • 0.00%

    28 Oct 2020

0.00%

28 Oct 2020
  • Appendix 3G

    Issued Capital

  • -9.09%

    27 Oct 2020

-9.09%

27 Oct 2020
  • Initial Director's Interest Notice

    Shareholder Details

  • -9.09%

    27 Oct 2020

-9.09%

27 Oct 2020
  • Activities Report and Appendix 4C

    Commitments test entity quarterly reports · Market sensitive

  • 0.00%

    25 Oct 2020

0.00%

25 Oct 2020
  • Director Appointment

    Company Administration

  • 0.00%

    25 Oct 2020

0.00%

25 Oct 2020
  • Results of Annual General Meeting

    Notice Of Meeting

  • 0.00%

    21 Oct 2020

0.00%

21 Oct 2020
  • AGM Presentation

    Chairman's Address

  • 0.00%

    21 Oct 2020

0.00%

21 Oct 2020
  • Grant of ASX Waiver

    Shareholder Details

  • 0.00%

    20 Sep 2020

0.00%

20 Sep 2020
Market Data

Current Price

$0.011

52WK HIGH

$0.026

52WK LOW

$0.006

1YR RETURN

-15.38%

1YR RETURN VS. SECTOR

-30.77%

90 DAY RETURN

+22.22%

ASX RANK

975

/2,013

SECTOR RANK

12

/30

SHARES OUTSTANDING

5.50b
ASX:IVX

INVION LIMITED

Health Care

Invion Limited (IVX) is a clinical-stage drug development company in the biotechnology and pharmaceutical industry in Australia. IVX has three key development programs: INV102 for inflammatory respiratory disease; INV104, a leukotriene receptor antagonist; and, INV103, a modified, naturally occurring human protein. Former Names Cbio Limited (CBZ), 04/09/2012.

Read more

Market Cap

60.54m

Price at Close

$0.011

4w avg. Volume

821.26k

4w avg. Turnover

$8.57k

ASX:IVX is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.